NG Bio
Mohammad Khobreh is a highly experienced professional who holds various positions in multiple companies. Currently serving as a Managing Partner and Co-founder at NG Bio, Partner and Investment Committee Member at One Rosemond, Board Member at Bastion Therapeutics, Investor at LightOx and Abselion, Founder and CEO at Piccadilly Prime Ltd., Investor and Board Member at Day Pharmaceutical Complex and QMAB, and Board Member at Lian Chemical and Behnan Gandom. Mohammad holds a Master's degree in Risk Management from Bayes Business School, with previous education in Corporate Law and Governance from The London School of Economics and Political Science, and A-Levels from DLD College London.
This person is not in any teams
This person is not in any offices
NG Bio
At NG Bio we build therapeutic ventures that can change outcomes for patients with autoimmune and chronic inflammatory diseases. Our team of scientists, drug developers and entrepreneurs work with academic and scientific founders to give their technologies the highest chance to getting to the patients who need them most.